- Sanofi India Limited (NSE: SANOFI, BSE: 500674) received a GST Show‑Cause Notice (Section 74 CGST Act) on 28 August 2026, alleging it mis‑classified FY 2020‑21 products at 5 % instead of the applicable 12 % rate.
- The authority has proposed a tax demand of ₹ 36,38,70,979 and an equal penalty of ₹ 36,38,70,979 (≈ ₹ 36.39 crore each).
- After consulting tax advisors, the company says it does not anticipate any adverse impact on its financial statements, operations or cash flow, and has recorded no liability yet.
- Sanofi India Limited will examine the notice and submit a reply within the prescribed timeframe, keeping the market informed of material developments.
- The disclosure complies with SEBI Regulation 30 (Listing Obligations) and related master circular requirements.
Sanofi India has received a GST show‑cause notice with a potential outflow of about ₹73 crore, but the company says it expects no material impact. The market is likely to react modestly, with the stock staying roughly flat in the near term.
Sign in for impact outlook, horizons, comparables, and full intelligence analysis.
Forecast from comparable, historic events. Not investment advice.
Frism is a financial information and news discovery platform. We provide factual summaries and data correlations for educational and informational purposes only. Frism does not provide investment advice, buy/sell recommendations, or directional market outlooks. Users should consult a qualified financial advisor before making any investment decisions.
Frism Computing (OPC) Private Limited
#74, 15TH CROSS, JP Nagar III Phase, Bangalore South, Bangalore 560078, Karnataka